Research programme: prNP RNA therapeutics - Nanophoria Bioscience
Alternative Names: prNP RNA therapeutics - Nanophoria BioscienceLatest Information Update: 08 Mar 2024
At a glance
- Originator NanoPhoria Bioscience
- Class Heart failure therapies; RNA
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Heart failure; Lung disorders
Most Recent Events
- 27 Feb 2024 Early research in Heart failure in Italy (Parenteral) (Nanophoria Bioscience pipeline, February 2024)
- 27 Feb 2024 Early research in Lung disorders in Italy (Parenteral) (Nanophoria Bioscience pipeline, February 2024)